SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007081
Filing Date
2024-05-07
Accepted
2024-05-07 16:51:57
Documents
58
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ptgx-20240331x10q.htm   iXBRL 10-Q 1356268
2 EX-10.1 ptgx-20240331xex10d1.htm EX-10.1 981830
3 EX-31.1 ptgx-20240331xex31d1.htm EX-31.1 10154
4 EX-31.2 ptgx-20240331xex31d2.htm EX-31.2 10179
5 EX-32.1 ptgx-20240331xex32d1.htm EX-32.1 10082
6 GRAPHIC ptgx-20240331x10q006.jpg GRAPHIC 99898
  Complete submission text file 0001558370-24-007081.txt   6848509

Data Files

Seq Description Document Type Size
7 EX-101.SCH ptgx-20240331.xsd EX-101.SCH 39040
8 EX-101.CAL ptgx-20240331_cal.xml EX-101.CAL 48083
9 EX-101.DEF ptgx-20240331_def.xml EX-101.DEF 134322
10 EX-101.LAB ptgx-20240331_lab.xml EX-101.LAB 292086
11 EX-101.PRE ptgx-20240331_pre.xml EX-101.PRE 234664
62 EXTRACTED XBRL INSTANCE DOCUMENT ptgx-20240331x10q_htm.xml XML 878187
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 24922881
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)